HT
TWST icon

Headlands Technologies’s Twist Bioscience TWST Stock Holding History

Headlands Technologies’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,974
Closed -$315K – 1604
2024
Q3 		$315K Buy
6,974
+1,956
+39% +$93.1K 0.04% 419
2024
Q2 		$247K Buy
5,018
+1,405
+39% +$57.3K 0.03% 426
2024
Q1 		$124K Buy
+3,613
New +$130K 0.03% 494
2023
Q2 		– Sell
-85
Closed -$1.28K – 1007
2023
Q1 		$1.28K Buy
+85
New +$1.88K ﹤0.01% 447

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Headlands Technologies's TWST Position: Q4 2024 in Review

Headlands Technologies sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 6,974 shares — an estimated $315K sold.

Headlands Technologies first reported a position in TWST in Q1 2023 and held it in 4 quarters. The position peaked at $315K in Q3 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Headlands Technologies reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • Headlands Technologies sold 6,974 Twist Bioscience shares in Q4 2024, an estimated $315K.
  • Headlands Technologies first reported a position in Twist Bioscience in Q1 2023 and held it in 4 quarters.
  • Headlands Technologies's Twist Bioscience position peaked at $315K in Q3 2024.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Headlands Technologies's 13F filing for Q4 2024, filed 12 Feb 2025.